Adjuvant and neoadjuvant therapy in non-small cell lung cancer

Seminars in Oncology

Volumn 32, Issue SUPPL. 2, 2005, Pages S9-

  Belani, Chandra P ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GEFITINIB; GEMCITABINE; IFOSFAMIDE; LOMUSTINE; MITOMYCIN C; NAVELBINE; PACLITAXEL; UFT; VINBLASTINE; VINCRISTINE; VINDESINE;

ARTICLE; BONE MARROW APLASIA; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; FEBRILE NEUTROPENIA; GENE MUTATION; HEARING IMPAIRMENT; HUMAN; HYPONATREMIA; INTERMETHOD COMPARISON; KIDNEY FAILURE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; METASTASIS; NEUROPATHY; NEUROTOXICITY; NEUTROPENIA; PARESTHESIA; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR DIFFERENTIATION; TUMOR VOLUME; VOMITING;

EID: 16244370728     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2005.02.005     Document Type: Article

References (32)

1. C.F. Mountain, C.M. Dresler Regional lymph node classification for lung cancer staging Chest 111 1997 1718 1723
2. F.C. Detterbeck, D.R. Jones Surgery for stage I non-small cell lung cancer F.C. Detterbeck M.P. Rivera M.A. Socinski Diagnosis and Treatment of Lung Cancer An Evidence-Based Guide for the Practicing Clinician 2001 Saunders Philadelphia, PA 283 290
3. F.C. Detterbeck, D.R. Jones Surgical treatment of stage IIIA (N2) non-small cell lung cancer F.C. Detterbeck M.P. Rivera M.A. Socinski Diagnosis and Treatment of Lung Cancer An Evidence-Based Guide for the Practicing Clinician 2001 Saunders Philadelphia, PA 244 256
4. K. Albain, C. Scott, V. Rusch Phase III comparison of concurrent chemotherapy plus radiotherapy (CT/RT) and CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC) Initial results from intergroup trial 0139 (RTOG 93-09) Proc Am Soc Clin Oncol 22 2003 621 (abstr 2497)
5. A. Ohgami, T. Mitsudomi, K. Sugio Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer Ann Thorac Surg 64 1997 363 367
6. R. Arriagada, B. Bergman, A. Dunant Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 350 2004 351 360
7. S.M. Keller, S. Adak, H. Wagner Eastern Cooperative Oncology Group A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer N Engl J Med 343 2000 1217 1222
8. G.V. Scagliotti, R. Fossati, V. Torri Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer J Natl Cancer Inst 95 2003 1453 1461
9. E.C. Holmes, M. Gail Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma J Clin Oncol 4 1986 710 715
10. The Lung Cancer Study Group The benefit of adjuvant treatment for resected locally advanced non-small cell lung cancer. The Lung Cancer Study Group J Clin Oncol 6 1988 9 17
11. T.L. Winton, R. Livingston, D. Johnson A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage 1B and II non small cell lung cancer (NSCLC) Intergroup JBR.10 2004 Proc Am Soc Clin Oncol 22 2004 14S (abstr 7018)
12. G.M. Strauss, J. Herndon, M.A. Maddaus Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC) Report of Cancer and Leukemia Group B (CALGB) Protocol 9633 Proc Am Soc Clin Oncol 22 2004 14S (abstr 7019)
13. Y. Ichinose, N. Hara, M. Ohta Postoperative adjuvant chemotherapy in non-small cell lung cancer Prognostic value of DNA ploidy and post-recurrent survival J Surg Oncol 46 1991 15 20
14. A. Niiranen, S. Niitamo-Korhonen, M. Kouri Adjuvant chemotherapy after radical surgery for non-small cell lung cancer A randomized study J Clin Oncol 10 1992 1927 1932
15. M. Ohta, R. Tsuchiya, M. Shimoyama The Japan Clinical Oncology Group Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer. Results of a randomized prospective study J Thorac Cardiovasc Surg 106 1993 703 708
16. B. Dautzenberg, C. Chastang, R. Arriagada GETCB (Groupe d'Etude et de Traitement des Cancers Bronchiques) Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients Cancer 76 1995 779 786
17. T.C. Mineo, V. Ambrogi, V. Corsaro Postoperative adjuvant therapy for stage IB non-small-cell lung cancer Eur J Cardiothorac Surg 20 2001 378 384
18. D. Waller, D.J. Fairlamb, N. Gower The Big Lung Trial (BLT): Determining the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer. Preliminary results in the surgical setting Proc Soc Am Clin Oncol 22 2003 632 (abstr 2543)
19. H. Tada, R. Tsuchiya, Y. Ichinose A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304) Lung Cancer 43 2004 167 173
20. D. Waller, M.D. Peake, R.J. Stephens Chemotherapy for patients with non-small cell lung cancer The surgical setting of the Big Lung Trial Eur J Cardiothorac Surg 26 2004 173 182
21. Non-Small Cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-Small Cell Lung Cancer Collaborative Group BMJ 311 1995 899 909
22. H. Kato, M. Tsuboi, M. Ohta A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I adenocarcinoma of the lung Proc Am Soc Clin Oncol 22 2003 621 (abstr 2498)
23. H. Kato, Y. Ichinose, M. Ohta A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung N Engl J Med 350 2004 1713 1721
24. C. Hamada, M. Ohta, H. Wada Survival benefit of oral UFT for adjuvant chemotherapy after completely resected non-small-cell lung cancer Proc Am Soc Clin Oncol 23 2004 615 (abstr 7002)
25. R.J. Slebos, R.E. Kibbelaar, O. Dalesio K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung N Engl J Med 323 1990 561 565
26. M. Huncharek, J. Muscat, J.F. Geschwind K-ras oncogene mutation as a prognostic marker in non-small cell lung cancer A combined analysis of 881 cases Carcinogenesis 20 1999 1507 1510
27. G.V. Scagliotti, P. Masiero, E. Pozzi Biological prognostic factors in non-small cell lung cancer Lung Cancer 12 suppl 1 1995 S13 S25
28. U. Pastorino, S. Andreola, E. Tagliabue Immunocytochemical markers in stage I lung cancer Relevance to prognosis J Clin Oncol 15 1997 2858 2865
29. A. Depierre, B. Milleron, D. Moro-Sibilot Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer J Clin Oncol 20 2002 247 253
30. K.M. Pisters, R.J. Ginsberg, D.J. Giroux Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. Bimodality Lung Oncology Team J Thorac Cardiovasc Surg 119 2000 429 439
31. K.M. Pisters, R.J. Ginsberg, D.J. Giroux Bimodality lung oncology team (BLOT) trial of induction paclitaxel/carboplatin in early stage non-small cell lung cancer (NSCLC) Long term followup of a phase II trial Proc Soc Am Clin Oncol 22 2003 633 (abstr 2544)
32. C.F. Mountain New prognostic factors in lung cancer. Biologic prophets of cancer cell aggression Chest 108 1995 246 254